Upstream Processing Featured Articles

  1. NIH Scientists Map First Steps In Flu Antibody Development 8/29/2012

    National Institutes of Health scientists have identified how a kind of immature  immune cell responds to a part of influenza virus and have traced the path those cells take to generate antibodies that can neutralize a wide range of influenza virus strains. Study researchers from the National Institute of Allergy and Infectious Diseases (NIAID), part of NIH, were led by Gary Nabel, M.D., Ph.D., director of NIAID's Vaccine Research Center. Their findings appear online in advance of print in Nature.

  2. Agilent Technologies' Cary FT-IR Wins Industrial Design Award From Instrument Business Outlook 8/29/2012

    Agilent Technologies Inc. recently announced its Cary 630 FT-IR spectrometer has won the 2012 Instrument Business Outlook (IBO) Industrial Design Gold Award.

  3. GE Healthcare Launches ÄKTA™ Pure, A New Modular Chromatography System For Protein Purification 8/24/2012

    GE Healthcare, the healthcare business of GE announced recently the launch of ÄKTA™ pure, a chromatography system for flexible, reliable and intuitive purification of proteins. 

  4. New Data Confirm Mastersizer 3000 Is Breaking New Ground In Dry Powder Particle Sizing 8/22/2012

    New experimental data published by Malvern Instruments illustrate the real-world capability and flexibility of the Mastersizer 3000 laser diffraction system for the particle size measurement of dry powders.

  5. GE Healthcare Launches Ni Sepharose Excel Chromatography Media For Direct Purification Of Histidine-Tagged Proteins Secreted From Eukaryotic Expression Systems 8/21/2012

    GE Healthcare’s Ni Sepharose excel is an immobilized metal ion affinity chromatography (IMAC) medium (resin) for the direct capture and purification of secreted histidine-tagged recombinant proteins from eukaryotic cell culture supernatants. 

  6. Crucell And Scripps Research Discover And Describe Broad-Spectrum Antibodies Against Influenza B, A Crucial Link In Development Of Universal Flu Therapies And Vaccine 8/9/2012

    In a landmark discovery, researchers from Crucell Holland B.V. and The Scripps Research Institute, recently announced the identification of the first human monoclonal antibodies that appear capable of disabling all influenza B viruses. 

  7. Oncobiologics, Inc. Announces A Collaboration Agreement With XOMA Corporation To Utilize XOMA's Fully Human Antibody Libraries For Their Discovery Platform 7/30/2012

    Oncobiologics, Inc. announced recently a collaboration agreement with XOMA Corporation to develop novel biotherapeutics based on engineering single-chain variable fragments (scFv) into a bi-specific antibody scaffold.

  8. Thermo Fisher Scientific Introduces Next-Generation Benchtop LC-MS System At ASMS 2012 5/21/2012

    Thermo Fisher Scientific Inc., the world leader in serving science, recently announced the Thermo Scientific Exactive Plus system, the company’s latest benchtop liquid chromatography-mass spectrometry (LC-MS) system for high-throughput screening, identification and quantification of compounds in complex matrices.

  9. Evotec Becomes The First Contract Research Facility In Europe To Offer Agilent's RapidFire/MS Screening For Pharmaceutical Drug Discovery 5/16/2012

    Evotec AG is proud to announce the addition of Agilent Technologies' RapidFire Mass Spectrometry analysis capabilities to their High Throughput Screening facilities in Hamburg.

  10. GlaxoSmithKline To Fully Acquire Cellzome For £61M 5/15/2012

    GlaxoSmithKline plc (GSK) recently announced that it has entered into an agreement to acquire those shares it does not currently own in Cellzome, a leader in the development and advancement of proteomics technologies, for £61 million (US$99M) in cash. Cellzome, a privately owned company with laboratories in Cambridge, UK, and Heidelberg, Germany, will become part of GSK’s R&D organisation.